So pharmaceutical research is largely an engineering problem, of running experiments and synthesizing molecules as fast, cheap and accurate as possible ?
It also seems to be a financial problem of getting VC funds to run trials to appease regulators. Even if you’ve already seen results in a lab or other country.
I wouldn't say it's an engineering problem. Biology and pharmacology are very complex with lots of curveballs, and each experiment is often different and not done enough to warrant full engineering-scale optimization (although this is sometimes the case!).